Protease inhibitors (class)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Protease inhibitors (class), covering 2013-10-07 to 2017-07-21. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa [Phase 3]